SOLIGENIX, INC. Derivative Liability
SOLIGENIX, INC. (SNGX) had Derivative Liability of $1.32 million as of 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2017-03-27
- 2016-09-30: Derivative Liability $1.32M.
- 2016-06-30: Derivative Liability $1.15M.
- 2016-03-31: Derivative Liability $1.67M.
- 2015-12-31: Derivative Liability $2.43M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2016-09-30 | $1.32M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.15M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.67M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $2.43M 10-K · filed 2017-03-27 | |
| 2015-09-30 | $2.14M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $6.20M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $5.15M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $3.79M 10-Q · filed 2015-11-12 | |
| 2014-09-30 | $7.43M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $8.77M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $9.52M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $8.22M 10-Q · filed 2014-11-10 | $8.28M 10-K · filed 2014-03-26 |
| 2013-09-30 | $9.98M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $5.18M 10-Q · filed 2013-08-12 | |
| 2012-12-31 | $2.68M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |